Financial Trends -- 5/10
A structurally declining-volume, high-margin cash machine. Revenue erodes ~2-3%/yr as cigarette
volumes fall ~10%/yr faster than pricing offsets (-2.7% 5yr CAGR), but the smokeable franchise keeps
expanding margins through net price realization, and a steady buyback compounds adjusted EPS at a
stable +4-6%. The trend is split: top line decelerating/declining, profitability mix (adjusted margin
+ EPS) improving, GAAP operating income lumpy and falling on NJOY impairments. High quality, no
growth -- stable revenue, expanding margins, shrinking shares, stable FCF. No penalty modifiers.
Weight: 25%
Smokeable OCI Margin
65.1%
Expanding ~+490bps | Core strength
TTM FCF
~$8.6B
~37% margin | Stable ~$9B
Adj EPS
$1.32
+7.3% YoY | Buyback-compounded
Quarterly Net Revenue ($M)
No durable acceleration -- revenue is persistently negative.
Net revenue is range-bound to declining as cigarette volumes fall ~10%/yr against ~+8% net
pricing. The 2026Q1 +3.2% "inflection" rides an easy 2025Q1 comp (which was -5.7%) and should be
treated as noise, not a genuine turn, until 2026Q2 confirms. Structural top-line erosion is the
binding constraint on this dimension.
Adjusted Diluted EPS ($) & Smokeable OCI Margin
Profitability engineering offsets the shrinking base.
Smokeable adjusted OCI margin expanded ~+490bps (Q1'24 to Q1'26) and adjusted EPS compounds at a
stable mid-single-digit rate even as revenue falls -- pricing power plus a ~2%/yr buyback. This is
the clearest positive in the financial profile and the reason the score sits at the "stable" 5
anchor rather than lower.
Annual Financial Summary (FY ends December)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net Revenue ($M) | $26,013M | $25,096M | $24,483M | $24,018M | $23,279M |
| Rev YoY | — | -3.5% | -2.4% | -1.9% | -3.1% |
| Gross Profit ($M) | $13,992M | $14,246M | $14,284M | $14,367M | $14,542M |
| Gross Margin | 53.8% | 56.8% | 58.3% | 59.8% | 62.5% |
| Adj Diluted EPS ($) | $4.61 | $4.84 | $4.95 | $5.12 | $5.42 |
| Adj EPS YoY | — | +5.0% | +2.3% | +3.4% | +5.9% |
| Smokeable OCI Margin | 57.6% | 59.0% | 59.9% | 61.6% | 63.4% |
| WA Diluted Shares (M) | 1,845 | 1,804 | 1,777 | 1,718 | 1,683 |
| Operating Cash Flow ($M) | $8,405M | $8,256M | $9,287M | $8,753M | $9,290M |
| Free Cash Flow ($M) | $8,236M | $8,051M | $9,091M | $8,611M | $9,074M |
| Total Debt ($M) | $28,044M | $26,680M | $26,233M | $24,926M | $25,709M |
Key trends
- Revenue in persistent decline (-2.7% 5yr CAGR): From $26.0B (2021) to $23.3B (2025) as cigarette volumes fall ~10%/yr, only partly offset by ~+8% net pricing
- Gross margin expanding +870bps: 53.8% (2021) to 62.5% (2025) despite lower revenue -- pricing power and mix
- Adj EPS compounding +4.1% CAGR: $4.61 to $5.42, a steady mid-single-digit rate driven by margins and buyback
- Share count declining -8.8%: 1,845M to 1,683M over five years, steady buyback with no dilution
- FCF stable ~$8.6-9.1B: Large, positive, high-margin (~36-39%) but range-bound -- stable, not accelerating
Segment Revenue Mix (FY2025, Net Revenues)
Trailing-Twelve-Month FCF (OCF − capex)
FCF positive and growing on a full-year basis. FY2025 FCF
of $9,074M (+5.4% vs FY2024's $8,611M) at a ~37% margin, funding ~$8B of annual capital return
($7B dividends + $1B buyback). Quarterly OCF is heavily distorted by MSA/settlement payment
timing, so FCF is assessed on a trailing-twelve-month basis -- range-bound ~$8.6-9.2B: stable,
not accelerating. Clears the positive-and-growing-FCF quality gate.
Blemishes -- Structural, Not Operational Deterioration
| Blemish | Detail | Penalty |
|---|---|---|
| Structural Revenue Decline | Net revenue -2.7% 5yr CAGR as cigarette volumes fall ~10%/yr; caps the upside (a 10 requires accelerating revenue, which MO lacks) | None |
| GAAP Op Income Lumpy | GAAP operating income both declining and lumpy -- NJOY's $1.3B e-vapor impairment crushed 2025Q1 and 2025Q4 GAAP results (impairment noise, not operating deterioration) | None |
| FCF Stable, Not Growing | FCF range-bound ~$8.6-9.2B -- stable, not accelerating; neutral in the rubric (no re-rate catalyst from cash growth) | None |
No penalty modifiers trigger. Negative FCF: no (FCF
strongly positive ~$9B). Share dilution: no (shares declining). Revenue up but operating income
down: N/A -- revenue is declining annually, so the trigger is not met. Debt growing faster than
revenue 3+ quarters: no (debt flat-to-down, leverage held at the ~2.0x EBITDA target). The
blemishes are structural/accounting, not operational.
Score Rationale
Score of 5/10 reflects a high-quality, cash-generative but no-growth financial profile. No penalty modifiers applied.
Anchors at 5 (stable):
- Revenue YoY is stable-to-slightly-declining (-2.7% 5yr CAGR) -- closer to the "5 = stable" anchor than the "1 = decelerating + compressing" anchor because margins are expanding and FCF is intact
- FCF is stable, not accelerating (range-bound ~$8.6-9.2B) -- neutral
Lifts off the base:
- Smokeable adjusted OCI margin expanding 100+bps (+580bps over 5yr, +490bps Q1'24 to Q1'26) -- the clearest positive
- Share count declining ~2%/yr, buyback-driven, no dilution
- Adjusted EPS compounding at a stable +4-6% ($4.61 to $5.42)
Holds it from a 6-7:
- Persistent structural top-line erosion -- a 10 requires accelerating revenue, which MO plainly does not have
- GAAP operating income declining and lumpy (NJOY $1.3B impairment distortion in 2025Q1/Q4)
- The 2026Q1 +3.2% revenue uptick is an easy-comp artifact, not a genuine inflection
Data sourced from Daloopa (company_id 261). Fiscal year ends December 31. All financials in USD. FCF = operating cash flow − capex; TTM rows are analyst roll-ups of Daloopa components.